MTOR and triple-negative breast carcinoma: Over time, the focus of the research field shifted from the application of mTOR inhibitors in the treatment of breast cancer to the mechanisms of the mTOR signaling pathway in the development of breast cancer, to the mechanism of resistance of mTOR inhibitors in the treatment of breast cancer, and the use of mTOR inhibitors in triple-negative breast cancer.